Catalyst Wire Dossier Catalyst Wire Dossier

Desvenlafaxine succinate sustained-release tablets

desvenlafaxine succinate
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Desvenlafaxine succinate sustained-release tablets, covering 2011-05-16 to 2024-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia in Patients With Major Depression Disorder [NA]

See pricing